Article navigation

A batch size model developed for the therapeutic product problem has been instrumental in assisting the staff of a large general hospital to resolve problems associated with the transactional process of the preparation of intravenous medications for administration. The model is a variation of a basic profit maximisation model and is characterised by variable batch preparation cost, a variable planning period, fixed per unit base cost, and zero shortage costs since preparation of a new batch can take place without delay. The variable planning period is transformed into a fixed planning horizon which is at least several multiples of the planning period and is fixed. Development of the model is presented and illustrated with a hypothetical situation, followed by a real case — the determination of the optimal batch size for the intravenous drug, Cefazolin.

This content is only available via PDF.
You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Pay-Per-View Access
$41.00
Rental

or Create an Account

Close Modal
Close Modal